Region
Featured experience
Guotai Junan merger with Haitong and concurrent placement of shares
We advised Guotai Junan Securities on the transaction, creating the largest securities company in China
Chagee $411.2 million IPO
We advised Chagee on its IPO and Nasdaq listing
Tencent €1.16 billion investment in new Ubisoft subsidiary
We are advising Tencent on the transaction
iQIYI $350 million convertible notes offering and concurrent private repurchases
We advised iQIYI on the transactions
Carsome Group $290 million Series E funding round
We are advising Carsome on its Series E funding round
CIFI Holdings $150 million notes offering
The high-yield notes are due 2026
China SCE $150 million senior notes offering
The high-yield notes are due 2024
BeiGene RMB22.2 billion Shanghai IPO
The offering, equivalent to $3.5 billion, is the largest biotech IPO to date in 2021
Xiamen ITG $300 million bonds offering
The 2.15% guaranteed bonds are due 2022
Yonghe HK$1.49 billion IPO
The shares are listed on the HKEX
CANbridge Pharmaceuticals HK$685 million IPO
We advised CANbridge Pharmaceuticals on its IPO and HKEX listing
Bilibili $1.6 billion sustainable convertible notes offering
The 0.5% convertible senior notes are due 2026
Blue Safari Group merger with Bitdeer Technologies
We are advising Blue Safari on the transaction
ANE HK$1.1 billion IPO
We advised ANE on its IPO and HKEX listing